A methodological scoping review on EMG processing and synergy-based results in muscle synergy studies in Parkinson’s disease
Frontiers in Bioengineering and Biotechnology · 06.01.2025 · 12
DOI: 10.3389/fbioe.2024.1445447 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 06.01.2025. Verfasst von Valentina Lanzani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Intelligent Industrial Systems and Technologies for Advanced Manufacturing (STIIMA), Italian Council of National Research (CNR), Milan, …. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell’Università e della Ricerca.
Abstract (Originalsprache)
Introduction
Parkinson’s Disease is the second most common neurodegenerative disease in the world. It affects mainly people over 65 and the incidence increases with age. It is characterized by motor and non-motor symptoms and several clinical manifestations. The most evident symptom that affects all patients with Parkinson’s Disease is the impairment of motor control, including bradykinesia, tremor, joint rigidity, and postural instability. In the literature, it has been evaluated with muscle synergies, a well-known method for evaluating motor control at the muscular level. However, few studies are available and there is still a major gap to fill to exploit the potential of the method for assessing motor control in Parkinson’s Disease, both in the understanding of physiopathology and clinical practice.
Methods
In the light of understanding and fostering future developments for the field, in this review we initially screened 212 papers on Scopus and Web of Science and selected 15 of them to summarize the main features of investigations that employed muscle synergies to analyze patients with Parkinson’s Disease. We detailed the features of the screened papers by reporting the clinical findings, a detailed report of EMG processing choices and synergy-based results.
Results
We found that synergistic control is in general altered in patients with Parkinson’s Disease, but it can improve if patients are subjected to pharmacological and rehabilitation therapies. Moreover, a further understanding of synergistic control in Parkinson’s patients is needed.
Discussion
We discuss the future developments in the field with a detailed assessment of the topic on the view of physicians, including the most promising lines of research for clinical practice and from the perspective of engineers, for methodological application of synergistic approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Intelligent Industrial Systems and Technologies for Advanced Manufacturing (STIIMA), Italian Council of National Research (CNR), Milan, Italy.
Förderung
- Ministero dell’Università e della Ricerca
Zitieren
APA
Lanzani, V., Brambilla, C., & Scano, A. (2025). A methodological scoping review on EMG processing and synergy-based results in muscle synergy studies in Parkinson’s disease. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1445447
Vancouver
Lanzani V, Brambilla C, Scano A. A methodological scoping review on EMG processing and synergy-based results in muscle synergy studies in Parkinson’s disease. Frontiers in Bioengineering and Biotechnology. 2025;12. doi:10.3389/fbioe.2024.1445447
BibTeX
@article{Lanzani2025,
author = {Lanzani, Valentina and Brambilla, Cristina and Scano, Alessandro},
title = {A methodological scoping review on EMG processing and synergy-based results in muscle synergy studies in Parkinson’s disease},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2025},
volume = {12},
doi = {10.3389/fbioe.2024.1445447}
}
EUVIMED